Gil Blum

Stock Analyst at Needham

(2.16)
# 2,703
Out of 4,863 analysts
389
Total ratings
36.78%
Success rate
-3.66%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Gil Blum

Sarepta Therapeutics
Jun 16, 2025
Maintains: Buy
Price Target: $125$50
Current: $21.56
Upside: +131.91%
Autolus Therapeutics
Jun 12, 2025
Reiterates: Buy
Price Target: $10
Current: $2.02
Upside: +395.05%
CRISPR Therapeutics AG
May 20, 2025
Reiterates: Buy
Price Target: $81
Current: $43.49
Upside: +86.25%
Celcuity
May 15, 2025
Reiterates: Buy
Price Target: $29
Current: $12.43
Upside: +133.28%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23$18
Current: $1.92
Upside: +837.50%
Absci
May 14, 2025
Reiterates: Buy
Price Target: $9
Current: $2.81
Upside: +220.28%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $63.66
Upside: +64.94%
Fate Therapeutics
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.29
Upside: -
Taysha Gene Therapies
Jun 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.61
Upside: +206.51%
Rocket Pharmaceuticals
May 27, 2025
Downgrades: Hold
Price Target: $42
Current: $2.80
Upside: +1,400.00%
Maintains: Buy
Price Target: $11$10
Current: $1.84
Upside: +443.48%
Reiterates: Buy
Price Target: $7
Current: $2.80
Upside: +150.00%
Maintains: Buy
Price Target: $41$40
Current: $10.46
Upside: +282.47%
Reiterates: Buy
Price Target: $8
Current: $0.40
Upside: +1,894.02%
Maintains: Buy
Price Target: $11$8
Current: $4.92
Upside: +62.77%
Reiterates: Buy
Price Target: $27
Current: $11.60
Upside: +132.76%
Reiterates: Buy
Price Target: $71
Current: $32.59
Upside: +117.86%
Reiterates: Buy
Price Target: $9
Current: $1.60
Upside: +462.50%
Reiterates: Buy
Price Target: $4
Current: $2.50
Upside: +60.32%
Reiterates: Hold
Price Target: n/a
Current: $0.99
Upside: -
Reiterates: Buy
Price Target: $5
Current: $1.48
Upside: +238.98%
Reiterates: Hold
Price Target: n/a
Current: $5.87
Upside: -
Reiterates: Buy
Price Target: $4
Current: $0.48
Upside: +738.05%